CRAT Antibody - BSA Free

Western Blot: CRAT Antibody [NBP1-86616]

Western Blot: CRAT Antibody [NBP1-86616] - Analysis using Anti-CRAT antibody NBP1-86616 (A) shows similar pattern to independent antibody NBP1-86615 (B).

Western Blot: CRAT Antibody - BSA Free [NBP1-86616]

Analysis in human cell line TD47D.

Western Blot: CRAT Antibody - BSA Free [NBP1-86616] -

Reduced FAO enzymes and morphological changes in mitochondria following the decline in OCTN2 occur in SDT-f-DKD rats.(A) Plasma free Car (nmol/L) and (B) ratio of short-chain Acyl-C/middle-to-long-chain Acyl-C over the time course of SDT-f-DKD. (C) Western blots for OCTN2, CPT1a, CPT2, CrAT, and beta -actin in the kidneys of SDT-f-DKD rats and (D) corresponding quantitation over the time course of SDT-f-DKD. n = 4, respectively. (E) Real-time PCR for Tmlhe in the kidneys of SDT-f-DKD rats at 7, 9, 12, and 17 weeks. n = 4, respectively. (F) Representative images of Oil Red O staining, immunofluorescence staining for KIM-1, and Picrosirius red staining over the time course of SDT-f-DKD and (G) the corresponding quantitation for Oil Red O+ area/cortex (%), KIM-1+/cortex (%), and collagen deposition area/cortex (%). Scale bar: 50 μm. n = 4, respectively. Data are presented as means +/- SD. One-way ANOVA with Tukey’s post hoc test (A, B, D, E, and G) were performed to determine P value. **P < 0.01, ***P < 0.001, and ****P < 0.0001. Tmlhe, trimethyllysine hydroxylase, epsilon; wks, weeks; LTL, lotus tetragonolobus lectin. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/40402578), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: CRAT Antibody - BSA Free [NBP1-86616] -

Salt-sensitive hypertension partially induces PTC carnitine deficiency with reduced plasma free Car.(A) Line graph shows systolic BP (mmHg) over time in Dahl-NS (n = 6), Dahl-HS (n = 7), and Dahl-HS+L-car (n = 6). (B) Plasma free Car (nmol/L) and (C) ratio of short-chain Acyl-C/middle-to-long-chain Acyl-C. (D) Western blots for CPT1a, CPT2, CrAT, and beta -actin in the kidneys of Dahl-NS and Dahl-HS and (E) corresponding quantitation. n = 4, respectively. (F) Representative images for OCTN2 and (G) the corresponding quantitation for OCTN2+/HPF (%) in Dahl-NS (n = 6), Dahl-HS (n = 7), and Dahl-HS+L-car (n = 6). Scale bar, 50 μm. (H) Real-time PCR for Tmlhe in the kidneys of Dahl-NS and Dahl-HS. n = 4, respectively. (I) Representative images of Oil Red O staining, immunofluorescence staining for KIM-1, and Picrosirius red staining in Dahl-NS, Dahl-HS, and Dahl-HS+L-car. Scale bar, 50 μm. (J) The corresponding quantitation for Oil Red O+ area/cortex (%), KIM-1+/cortex (%), and collagen+ area/cortex (%). n = 4, respectively. Data are presented as means +/- SD. Unpaired, 2-tailed Student’s t test (B, C, E, and H) and 1-way ANOVA with Tukey’s post hoc test (G and J) were performed to determine P value. *P < 0.05, ***P < 0.001, ****P < 0.0001. NS, normal salt. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/40402578), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: CRAT Antibody - BSA Free [NBP1-86616] -

FAO-related transporter and enzymes are reduced in SDT-f-DKD rats.(A) Western blots for OCTN2, CPT1a, CPT2, CrAT, and beta -actin in the kidneys of SD, SDT-f, and SDT-f-DKD rats. (B) Quantification of OCTN2/ beta -actin, (C) CPT1a/ beta -actin, (D) CPT2/ beta -actin, and (E) CrAT/ beta -actin in SD (n = 4), SDT-f (n = 4), and SDT-f-DKD rats (n = 4). (F) Western blots for p-AMPK, AMPK, PGC-1 alpha, and beta -actin in SD, SDT-f, and SDT-f-DKD rats. (G) Ratio of p-AMPK/AMPK and (H) quantification of PGC-1 alpha / beta -actin in SD (n = 4), SDT-f (n = 4), and SDT-f-DKD rats (n = 4). Data are presented as means +/- SD. One-way ANOVA with Tukey’s post hoc test (B–E, G, and H) were performed to determine P value. *P < 0.05, **P < 0.01, and ***P < 0.001. OCTN2, organic cation transporter 2; CPT1a, carnitine palmitoyltransferase 1a; CPT2, carnitine palmitoyltransferase 2; CrAT, carnitine acetyltransferase; p-AMPK, phosphorylated AMP-activated protein kinase; PGC-1 alpha, peroxisome proliferator–activated receptor-gamma coactivator-1 alpha. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/40402578), licensed under a CC-BY license. Not internally tested by Novus Biologicals.